4//SEC Filing
Stacey Jennifer Evans 4
Accession 0001209191-09-044653
CIK 0001182129other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 7:17 PM ET
Size
17.0 KB
Accession
0001209191-09-044653
Insider Transaction Report
Form 4
Stacey Jennifer Evans
Executive VP & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2009-09-14$9.15/sh+1,500$13,725→ 14,715 total - Sale
Common Stock
2009-09-14$35.43/sh−6,333$224,390→ 9,382 total - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2009-09-14−3,833→ 93,501 totalExercise: $5.36Exp: 2015-03-16→ Common Stock (3,833 underlying) - Exercise/Conversion
Common Stock
2009-09-14$13.16/sh+1,000$13,160→ 15,715 total - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2009-09-14−1,500→ 40,500 totalExercise: $9.15Exp: 2016-06-06→ Common Stock (1,500 underlying) - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2009-09-14−1,000→ 37,363 totalExercise: $13.16Exp: 2017-02-23→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2009-09-14$5.36/sh+3,833$20,545→ 13,215 total
Footnotes (4)
- [F1]The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 6, 2008.
- [F2]The shares underlying this option fully vested on March 16, 2009.
- [F3]11,250 shares underlying this option vested on each of June 6, 2007, June 6, 2008 and June 6, 2009. The remaining 11,250 shares will vest on June 6, 2010.
- [F4]10,000 shares underlying this option vested on each of February 23, 2008 and February 23, 2009. The remaining 20,000 shares will vest in two equal annual installments on February 23, 2010 and February 23, 2011.
Documents
Issuer
AUXILIUM PHARMACEUTICALS INC
CIK 0001182129
Entity typeother
Related Parties
1- filerCIK 0001321326
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 7:17 PM ET
- Size
- 17.0 KB